Patent ID: 7576127

Claim:
A method of treating migraine in a patient comprising administering to a patient in need thereof a pharmaceutical composition comprising a compound of Formula (I): or a pharmaceutically acceptable salt or N-oxide thereof, and a pharmaceutically acceptable vehicle, wherein: n is 0; Y is selected from the group consisting of a bond and O; A is CR 4 ; B is CR 5 ; D is CR 6 ; E is CR 7 ; G is CR 8 ; R 4 is selected from the group consisting of hydrogen and —W[C(O)] k Z(CR 9 R 10 ) r CO 2 R 11 ; R 5 is selected from the group consisting of hydrogen and —W[C(O)] k Z(CR 9 R 10 ) r CO 2 R 11 ; R 6 is selected from the group consisting of hydrogen and —W[C(O)] k Z(CR 9 R 10 ) r CO 2 R 11 ; R 7 is selected from the group consisting of hydrogen and —W[C(O)] k Z(CR 9 R 10 ) r CO 2 R 11 ; R 8 is selected from the group consisting of hydrogen and —W[C(O)] k Z(CR 9 R 10 ) r CO 2 R 11 ; W is a bond; Z is NR 17 ; k is 1; r is 1, 2 or 3; each of R 9 ,R 10 , and R 11 is hydrogen; R 17 is hydrogen; R 18 is hydrogen, alkyl, substituted alkyl, alkoxycarbonyl, aryl, substituted aryl, arylalkyl, carbamoyl, substituted carbamoyl, cycloalkyl, substituted cycloalkyl, cycloheteroalkyl, heteroaryl, substituted heteroaryl and heteroarylalkyl; with the proviso that: one and only one of R 4 ,R 5 ,R 6 ,R 7 or R 8 is —W[C(O)] k Z(CR 9 R 10 ) r CO 2 R 11 .